Skip to main content

Key Product Details

Species Reactivity

Virus

Applications

ELISA, Functional, Immunocytochemistry/ Immunofluorescence, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 Clone # 11-2-F3

Format

BSA Free

Concentration

1 mg/ml

Product Specifications

Immunogen

Gradient-purified RSF-44 virus (subgroup A) UV inactivated for 20 minutes at 20C

Specificity

This antibody reacts with the RS virus fusion glycoprotein F (also named VP70 or F0 protein), specifically to a subunit of the F protein, F1 (also named VGP48 or 48kDa), from both subgroups A and B of RS virus.This antibody has a high neutralising activity; 90% plaque neutralization titre of 102.2 (Gimenez et al 1996). This property makes it potentially useful for the preparation of reagents for prevention and/or therapeutic use (for example, vaccines or new-generation of man-made antibodies). The characterisation of the epitope of this antibody which induce high neutralising activity will be useful for the preparation of reagents (for example vaccine) to prevent RS virus infection. A RS virus vaccine is not yet available. A vaccine could be used to increase the maternal immunity to RS virus, which would then be passed to the newborn baby to provide passive immunity.The further characterisation of the epitope recognised by this antibody, which possesses a high neutralising activity, will be useful for the preparation of reagents to prevent RS virus infection. New-generation man-made antibodies, based on the 11-2-F3 antibody, could complement the effectiveness of polivizumab (Synagis), which is used to prevent but not treat established RS virus infections (Nature Biotechnology, 2013, 31, 952).

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1

Scientific Data Images

Western Blot: Respiratory Syncytial Virus Glycoprotein F Antibody (11-2-F3)BSA Free [NBP2-50412]

Western Blot: Respiratory Syncytial Virus Glycoprotein F Antibody (11-2-F3)BSA Free [NBP2-50412]

Western Blot: Respiratory Syncytial Virus Glycoprotein F Antibody (RSV 11-2-F3) [NBP2-50412] - The antigen present in all lanes was gradient purified RSN-A2 virus (subgroup A). First antibodies: lanes “mAb”: 11-2-F3 antibody; lanes “Hus”: RS virus convalescent human sera. Panel A: Antigen analysed by electrophoresis using reducing conditions (SDS and mercapthoethanol). Panel B: Antigen analysed by electrophoresis using non reducing conditions (SDS only) (Gimenez et al., 1986). The identity and molecular weight of the protein target of this antibody was validated by including within the immunoblot assay (as a marker) a convalescent serum sample from a RS virus infected patient.

Applications

Application
Recommended Usage

ELISA

1:100 - 1:2000

Immunocytochemistry/ Immunofluorescence

1:10 - 1:500

Western Blot

1:100 - 1:2000
Application Notes
Positive control(s): Immunoblot: Ag: gradient-purified Respiratory Syncytial Virus. Indirect immunofluorescence: staining of RSA-2 infected BSC-1 cells.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: Respiratory Syncytial Virus Glycoprotein F

Alternate Names

Fusion glycoprotein F0, Fusion glycoprotein F1, Fusion glycoprotein F2

Additional Respiratory Syncytial Virus Glycoprotein F Products

Product Documents

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...